rss feeds Last update Booming mobile health app market needs more FDA oversight for ..., 3 hours ago

Medications news

FDA approves hard-to-abuse narcotic painkiller

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Jul 25, 2014
popularity 3.7 / 5 (3) | comments 0

Tough-to-abuse formulation of oxycodone approved

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

Jul 25, 2014
popularity not rated yet | comments 0

Physicians warned about counterfeit medical devices

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Jul 24, 2014
popularity not rated yet | comments 0

EU regulator: Morning-after pill OK for all women

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Jul 24, 2014
popularity 5 / 5 (1) | comments 0

Zydelig approved for three types of blood cancer

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Jul 24, 2014
popularity not rated yet | comments 0

Supermaterial gives rejected drugs a new chance

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Jul 22, 2014
popularity 4.5 / 5 (2) | comments 0

NIH system to monitor emerging drug trends

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

Jul 17, 2014
popularity not rated yet | comments 0

Ruconest approved for rare genetic disease

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

Jul 17, 2014
popularity not rated yet | comments 0

More News Stories

Novartis to use Google technology for eye care

Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.

Changes in generic pill color and shape disrupt use

Generic versions of the same prescription drug are clinically interchangeable but often look different depending on the manufacturer. The FDA does not require consistent pill appearance among interchangeable generic drugs, ...

Animal vaccines should guide malaria research

Research into vaccines for malaria in humans should be guided by the success shown in producing effective vaccines for malaria-like diseases in animals, according to a University of Adelaide study.

Express Scripts cuts payments for customized drugs

The nation's largest pharmacy benefit manager, Express Scripts, is dramatically scaling back its coverage of compounded medications, saying most of the custom-mixed medicines are ineffective or overpriced.

Other Spotlight Stories

Find more Medications news articles via sort by date page